Coriell Life Sciences
Coriell Life Sciences, headquartered in Philadelphia, specializes in pharmacogenomics and precision medicine to enhance healthcare outcomes and reduce costs through genetic testing and personalized medicine initiatives.
Services
Coriell Life Sciences employs pharmacogenomics and precision medicine to improve healthcare outcomes and reduce costs. The company offers the Corigen® Medication Safety Program, designed to optimize drug therapies through DNA testing. By analyzing how genes affect a person's response to medications, they provide personalized treatment plans. They also conduct research analysis in specific medical areas such as women's health, urinary tract infections, and respiratory pathogen panel testing.
Products
Coriell Life Sciences offers Corigen®, a Medication Safety Program aimed at optimizing drug therapies. This program uses DNA testing to analyze how genes affect an individual's response to medications. By leveraging these genetic insights, Corigen® helps to identify the most effective and safe medication plans for patients, reducing risks and improving treatment outcomes.
Partnerships
Coriell Life Sciences partners with healthcare providers, employers, and payers to integrate genetic science into benefits plans. Additionally, the company engages in collaborations with academic institutions, health systems, and laboratories. These partnerships aim to enhance healthcare through the application of genetic science, making precision medicine more accessible and effective.
Headquarters
Coriell Life Sciences is headquartered in the Philadelphia Navy Yard. This location underscores the company's emphasis on innovation in precision medicine genetics. From this base, Coriell Life Sciences leads initiatives in personalized medicine and seeks to make healthcare more efficient through the application of genetic insights.